Navigation Links
China Biologic Reports Financial Results for the Second Quarter and First Half of 2012
Date:8/9/2012

BEIJING, Aug. 9, 2012 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced its unaudited financial results for the second quarter of 2012.

Second Quarter 2012 Financial Highlights

  • Total sales in the second quarter of 2012 increased by 21.1% to $50.5 million from $41.7 million in the same quarter of 2011.
  • Gross profit increased by 17.8% to $34.3 million from $29.2 million in the same quarter of 2011. Gross margin was 68.0% in the second quarter of 2012 compared with 70.0% in the second quarter of 2011.
  • Income from operations increased by 23.7% to $21.3 million from $17.2 million. The operating margin was 42.2% in the second quarter of 2012 compared with 41.4% in the second quarter of 2011.
  • Net income attributable to the Company was $12.8 million, a decrease of 22.7% from $16.6 million in the same quarter of 2011. Non-GAAP adjusted net income attributable to the Company was $13.3 million or $0.50 per diluted share in the second quarter of 2012, representing a 52.2% increase from $8.7 million or $0.33 per diluted share in the same quarter of last year.
  • Mr. David (Xiaoying) Gao, Chairman and chief executive officer ("CEO") of China Biologic, commented, "The latest quarter and first half of the year represented periods of positive change and growth at the Company. In the second quarter, both sales and income from operations grew over 20%. Non-GAAP adjusted net income attributable to the Company increased 52.2% to $13.3 million. As of the end of the first half of 2012, we have achieved over 50% of our full-year revenue target. Our direct sales model allows us to achieve better margins on most of our products and we also experienced increased market demand due to industry supply shortage for most plasma products during the period."

    "We are also pleased t
    '/>"/>

    SOURCE China Biologic Products, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

    Related biology technology :

    1. China Cord Blood Corporation Files its Annual Report on Form 20-F
    2. In Vitro Diagnostics (IVD) - Emerging Countries (Brazil, Russia, India, China) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2018
    3. Pressure BioSciences, Inc. Continues Global Sales Reach Expansion with Distribution Agreements for China, Vietnam, Laos, Cambodia, Australia, and New Zealand
    4. China Cord Blood Corporation Continues Share Repurchase Program
    5. Journal of Renewable and Sustainable Energy highlights energy trends in China
    6. WuXi PharmaTech Named a Top Ten Outsourcing Enterprise in China for Five Consecutive Years
    7. Sinovac to Present at 55th Annual BioPharma China Convention 2012 - Vaccine & Antibody Focus
    8. China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2012
    9. China Integrated Energy Inc. Completes Independent Investigation
    10. China Biologic Products Names Chairman David Gao to Additional Post of CEO
    11. China Pharma Holdings, Inc. to Report First Quarter of Fiscal Year 2012 Financial Results on May 15, 2012
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/1/2015)... Branford, Conn. (PRWEB) , ... September 01, 2015 ... ... development of high-quality recombinant antibodies, announced today that the National Institutes of Health ... grant (1R41DK104602-01), which will be administered by the NIH’s National Institute of Diabetes ...
    (Date:9/1/2015)... ... September 01, 2015 , ... ... in the neuro and pain management space join prominent academics and key investors ... Center at Harvard Medical School in Boston. , Neuro Advance Boston focuses ...
    (Date:9/1/2015)... ... September 01, 2015 , ... Industry leader iLab ... Pacific. In this newly-created position, Gibbs will lead iLab’s business operations in the ... of tools. This entails not only introducing iLab to potential partners but support ...
    (Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... announced the release of a groundbreaking new version of its flagship DNA design ... methodology breaks down complex DNA sequences into numerous genetic parts, which in turn ...
    Breaking Biology Technology:AxioMx Announces Receipt of SBIR Grant for DNA-Protein Complex Antigen Development 2AxioMx Announces Receipt of SBIR Grant for DNA-Protein Complex Antigen Development 3Neuro Advance Boston Brings Together Leading Neuroscience Experts on October 14 at Harvard Medical School 2iLab Solutions Hires Gerard Gibbs, Director of Business Development, Asia Pacific 2iLab Solutions Hires Gerard Gibbs, Director of Business Development, Asia Pacific 3GenoCAD Releases Combinatorial Design Tool to Optimize Protein Expression and Streamline DNA Synthesis Orders 2
    ... PDS Biotechnology today announced,that the company has obtained ... Merck Eprova,s proprietary chiral lipid DOTAP Chloride in,Versamune(TM)-HPV ... Versamune(TM),technology. The use of enantiomerically pure DOTAP ... Merck Eprova AG will be providing,enantiomerically pure ...
    ... of Care managers can now quickly and easily ... organization,s environment of care (EC) compliance with ... audio interviews with EC experts called "EC Bits."EC Bits ... http://www.eheinc.com/ec_bits.htm feature expert advice to help keep EC ...
    ... ALTO, Calif., Feb. 24 Eiger BioPharmaceuticals, Inc.,a ... has raised $7.1 million in a Series A ... two firms were instrumental in the formation,of the ... represented on the board of,directors by general partners ...
    Cached Biology Technology:PDS Biotechnology Corporation Finalizes Commercial Licensing Agreement with Merck Eprova AG to Utilize Merck Eprova's Enantiomers of DOTAP Chloride in Immunotherapies 2Web-based Audio Interviews Keep Environment of Care Managers Up-to-Date on Key EC Compliance Issues 2Eiger BioPharmaceuticals Raises $7.1 Million 'A' Round 2
    (Date:8/18/2015)... Aug. 17, 2015 Research and Markets ... the "Global Biometric Authentication & Identification Market: ... & Forecast, 2015-2020" report to their offering. ... identification systems market is expected to grow at ... 2020 and generate over $25 billion (approximately) by ...
    (Date:8/12/2015)...   MedNet Solutions , an innovative SaaS-based eClinical ... research, is proud to announce that iMedNet ... technology platform, has led the way to significant and ... 2015.   Q2 2015 and Q1 2015 were, respectively, ... value sold in the company,s 15 year history.  In ...
    (Date:8/12/2015)... , Aug. 12, 2015  New research ... can attack Android phones to steal users, fingerprints. ... increasing availability of fingerprint scanners on mobile devices, ... concern. To secure biometrics on mobile devices, HYPR ... augment these convenient authentication systems with strong cryptographic ...
    Breaking Biology News(10 mins):Global Biometric Authentication & Identification Market 2015: Focus On Modality, Motility & Application - Estimation & Forecasts to 2020 for the $25 Billion Industry 2MedNet Solutions Experiences Explosive Corporate Growth 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 3
    ... Virginia Tech,s Advanced Experimental Thermofluid Engineering Research ... professor Pavlos P. Vlachos, professor of mechanical engineering, ... mechanics from the Measurement Science and Technology ... Physics. John J. Charonko, of Blacksburg, ...
    ... -- Scientists Jingfeng Xiao and Scott Ollinger of the ... Earth, Oceans, and Space (EOS) have received funding from ... of competitively awarded grants for the agency,s new Macrosystems ... quantify continental-scale carbon fluxes or so-called carbon "sources" and ...
    ... the treeless, flat Prairie, you,d think a city would provide ... and roost in trees and buildings. But researchers at the ... landscape is far from ideal for these animals. "I ... and recent PhD graduate in biological sciences at the University ...
    Cached Biology News:Virginia Tech mechanical engineers win measurement science best paper award 2UNH researchers receive grant for pioneering carbon cycle model 2UNH researchers receive grant for pioneering carbon cycle model 3Big city holds empty promise for bats 2
    Dopamine D2 and D3 receptor, human and possibly mouse. AB1502 detects 40 ng of dopamine receptor peptide by ELISA. AB1502 is not neutralizing....
    STX18 Immunogen: STX18 (NP_058626, 101 a.a. ~ 200 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
    Mouse monoclonal [CLB-SW16 (formerly 708)] to CD42d (rating: ****) ( Abpromise for all tested applications). entrezGeneID: 2814 SwissProtID: P40197...
    Request Info...
    Biology Products: